Published by the Johns Hopkins Center for Health Security
Editors: Diane Meyer, RN, MPH; Divya Hosangadi, MSPH & Amanda Kobokovich, MPH
|
|
Public Health & Healthcare Preparedness
|
|
NEWS
A Rapid Deployment Team for Victims. It was quickly evident after the November 5, 2017, shooting that the sheer magnitude of the incident would require a surge of resources to assist survivors, witnesses, and the families of the injured and deceased. So Christopher Combs, the special agent in charge of the San Antonio FBI, called up what he described as one of the Bureau’s key “crisis assets”—the Victim Services Response Team (VSRT), a specially trained cadre of FBI personnel whose primary function is to address the needs of victims in mass casualty events.
(FBI, 4/8/19)
|
|
FUNDING OPPORTUNITY
Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity, and Security. The purpose of this program supports the achievement of the Global Health Security Agenda 12 targets that focus on protecting and improving health globally through Ministries of Health. Its purpose is to support immediate response efforts for the current Ebola outbreak, other infectious disease outbreaks or health threats, and Public Health Emergencies of International Concern (PHEICs). It is intended to build capacities to prevent, detect, respond to, and control infectious disease outbreaks, strengthen border security, and mitigate PHEICs and other health threats.
(Grants.gov, 4/5/19)
|
|
PRESS RELEASE
FDA and CBP Bolster Collaboration to Protect Public Health and Safety. The US Food and Drug Administration and the US Customs and Border Protection (CBP) leaders signed an agreement today to maximize inspection and detection capabilities in order to prevent illegal and harmful products entering the US through the nation’s International Mail Facilities (IMFs) and Ports of Entry that pose a threat to public health.
(FDA, 4/4/19)
|
|
REPORT
Harnessing Multilateral Financing for Health Security Preparedness. The economic consequences of large-scale disease outbreaks can be enormous: pandemics could cause $570 billion per year in average economic losses over the coming decades. Recent data demonstrates most countries would need to spend approximately $0.50-$1.50 per person per year to get an acceptable level of epidemic preparedness.
(CSIS, 4/3/19)
|
|
BLOG
Keeping Work with Select Agents Safe, Secure. Although potentially dangerous, work with select agents and toxins provides important scientific discoveries that have led to improved detection, prevention, diagnostic, and treatment options for diseases. Select agents and toxins are also considered to be some of the most threatening to the health and safety of people, plants and animals.
(CDC Public Health Matters Blog, 4/1/19)
|
|
WEBINAR
Introduction to the Pandemic Influenza Vaccine Campaign Planning Tool. This presentation will cover the use and functionality of the new interactive pandemic influenza vaccine campaign planning tool (PanVax). The tool is designed to help jurisdictions estimate pandemic influenza vaccination administration capacity, as highlighted in Domain 4 of the Public Health Emergency Preparedness (PHEP) Notice of Funding Opportunity, and improve their pandemic influenza vaccine campaign planning for the general public.
(NACCHO, 4/2019)
|
|
Homeland Security & Disaster Preparedness
|
|
NEWS
DOD Leaders Brief Congress on WMD Threats and Department’s Response. The lethality of the US military “depends on our warfighters’ ability to deter, prevent, protect against, mitigate, respond to, and recover from chemical, biological, radiological, or nuclear weapons and their effects, the deputy assistant secretary of defense for chemical and biological defense programs told Congress yesterday.
(DOD, 4/4/19)
|
|
MEETING
Implementation of the National Biodefense Strategy. The Biodefense Summit aims to engage the biodefense stakeholder community to inform national biodefense enterprise efforts to counter biological threats, reduce risk, prevent, prepare for, respond to, and recover from biological incidents. The Summit will inform implementation of the National Biodefense Strategy.
(ASPR PHE, 4/2/19)
|
|
Radiological & Nuclear Disaster Preparedness
|
|
Science & Technology Policy
|
|
NEWS
FDA Advancing Beneficial Animal Biotechnology Product Development. Last October, the FDA announced its Plant and Animal Biotechnology Innovation Action Plan, which focuses on the agency’s risk-based regulatory framework. This framework will help secure confidence in the safety and performance of plant and animal-based innovative products for consumers, patients, and America’s global trading partners.
(FDA, 4/2/19)
|
|
|
|
|
|
|
